Nachrichten zur CRISPR Therapeutics AG Aktie

Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy

Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential....…

Why did CRISPR Therapeutics stock soar today? Q2 results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why CRISPR Therapeutics Stock Is Jumping Today

Analysts continue to like this gene-editing stock....…

CRISPR Therapeutics (CRSP) Q2 Loss Narrower Than Expected

CRISPR Therapeutics (CRSP) second-quarter results beat the mark for both earnings and sales....…

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates

CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 55.05% and 2,085.45%, respectively, for the quarter ended June 2023.…

1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August

Crispr Therapeutics could be incredibly undervalued right now....…

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $55.44 in the latest trading session, marking a -0.14% move from the prior day....…

Is Now a Good Time to Buy CRISPR Therapeutics?

CRISPR shares have climbed more than 40% this year....…

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $57.75, marking a -0.81% move from the previous day....…

Crispr Therapeutics: Winken Milliarden-Umsätze?

Crispr Therapeutics könnte noch in diesem Jahr die Zulassung für das erste Medikament auf Grundlage der Crispr-Technologie erhalten....…

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $56.25 in the latest trading session, marking a +0.2% move from the prior day....…

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $56.23, moving +0.36% from the previous trading session....…

Is CRISPR Therapeutics Stock a Buy Now?

CRISPR stock has climbed more than 40% so far this year....…

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $56.89 in the latest trading session, marking a -1.49% move from the prior day....…

This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?

All eyes are on CRISPR Therapeutics gene editing technology....…

What 17 Analyst Ratings Have To Say About CRISPR Therapeutics

Latest Ratings for CRSP DateFirmActionFromTo Feb 2022RBC CapitalMaintainsSector Perform Feb 2022SVB LeerinkMaintainsOutperform Dec 2021Cowen & Co.Initiates Coverage OnMarket Perform…

Form 8-K CRISPR Therapeutics AG For: Jun 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Today, CRISPR has reached an important turning point....…

Why Is CRISPR Therapeutics AG (CRSP) Up 1.8% Since Last Earnings Report?

CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.621.894$

Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2023-05-30...…

CRISPR Therapeutics an outperform at William Blair on diversified pipeline

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health

Both stocks are recovering after big losses last year....…

Is CRISPR Therapeutics Stock a Buy Now?

The clinical-stage biotech company has been on the rise....…

CRISPR Therapeutics: Aktie im Aufwind - Aktienanalyse

Kulmbach (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der CRISPR Therapeutics AG…

CRISPR Therapeutics: Aktie feiert großes Comeback – historischer Meilenstein rückt näher

Der Risikoappetit nimmt an den Börsen allmählich wieder zu. Das lässt sich auch an einigen Kursen spekulativer Biotech-Titel ablesen. Im…

Final Trades: Berkshire, Devon Energy & CRISPR Therapeutics

The "Halftime Report" traders give their top picks to watch for the second half....…

Why CRISPR Therapeutics Stock Is on Fire Today

Thanks to the gene-editing pioneer having a pipeline chock-full of deep value and a possible regulatory approval on tap, investors…

Crispr Therapeutics Stock Climbs 13% on Narrower 1Q Loss

Crispr Therapeutics Stock Climbs 13% on Narrower 1Q Loss...…

CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat

CRISPR Therapeutics (CRSP) provides updates for its gene therapy candidates....…

CRISPR Therapeutics GAAP EPS of -$0.67 beats by $0.97, revenue of $100M beats by $75.67M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.13, moving +0.99% from the previous trading session....…

Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.266.637$

Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2023-04-25...…

Why CRISPR Therapeutics Just Became an Even Better Buy

Is this a no-brainer investment to add to your portfolio?...…

Why CRISPR Therapeutics Stock Is Marching Higher Today

This gene-editing stock has been heating up over the past week....…

Better Growth Stock: Axsome vs. CRISPR Therapeutics

These companies are both in the early days of their growth stories....…

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $50.31 in the latest trading session, marking a -0.49% move from the prior day....…

Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?

Here is how Bio-Rad Laboratories (BIO) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this…

Is CRISPR Therapeutics Stock a Buy Now?

The biotech could soon be a commercial-stage company....…

CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?

CRISPR Therapeutics AG (CRSP) saw its shares surge in the last session with trading volume being higher than average. The…

Why Shares of CRISPR Therapeutics Jumped Thursday

An independent drug-pricing group said that a $1.9 million cost for the companys exa-cel therapy would be cost-effective....…

Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet

The mean of analysts price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While…

Where Will CRISPR Therapeutics Be in 5 Years?

Could CRISPR Therapeutics be the next big healthcare stock?...…

CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $45.28, moving +0.11% from the previous trading session....…

Form 8-K CRISPR Therapeutics AG For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR Therapeutics sichert sich Lizenzgeschäft im Wert von bis zu 330 Mio. USD

Das 2013 gegründete Unternehmen wurde zwischen 2015 und 2019 jedes Jahr zu einem der TOP 100 Schweizer Startups gewählt....…

Form 8-K CRISPR Therapeutics AG For: Mar 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K CRISPR Therapeutics AG For: Mar 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Could CRISPR Therapeutics Become the Next Moderna?

Both companies use cutting-edge technology....…

CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals

CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals are part of the Zacks Industry Outlook article....…